PMEF
IDYA icon

Point72 Middle East FZE’s IDEAYA Biosciences IDYA Stock Holding History

Point72 Middle East FZE’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-8,239
Closed -$113K – 1788
2023
Q1 		$113K Buy
+8,239
New +$137K ﹤0.01% 1089

Other funds holding IDYA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Point72 Middle East FZE's IDYA Position: Q2 2023 in Review

Point72 Middle East FZE sold out of IDEAYA Biosciences (IDYA) in Q2 2023, closing a stake of 8,239 shares — an estimated $113K sold.

Point72 Middle East FZE first reported a position in IDYA in Q1 2023 and held it in 1 quarter. The position peaked at $113K in Q1 2023. 138 funds tracked by Wall St. Rank hold IDYA as of Q2 2023.

  • Point72 Middle East FZE reported no remaining IDEAYA Biosciences position as of Q2 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 8,239 IDEAYA Biosciences shares in Q2 2023, an estimated $113K.
  • Point72 Middle East FZE first reported a position in IDEAYA Biosciences in Q1 2023 and held it in 1 quarter.
  • Point72 Middle East FZE's IDEAYA Biosciences position peaked at $113K in Q1 2023.
  • 138 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2023.

Based on Point72 Middle East FZE's 13F filing for Q2 2023, filed 14 Aug 2023.